Comparative Benchmarking
In the context of the broader market, PHAR competes directly with industry leaders such as PHAT and DBVT. With a market capitalization of $1.11B, it holds a significant position in the sector. When comparing efficiency, PHAR's gross margin of N/A stands against PHAT's 86.72% and DBVT's 100.00%. Such benchmarking helps identify whether Pharming Group NV is trading at a premium or discount relative to its financial performance.
